As usual, I’m keeping a record of major stories in the media related to a recently published paper. I will continue to update this post to reflect the media response to our article in the Annals of Internal Medicine.
- Michael McCarthy from the BMJ covered the research, including asking extra questions.
- Melissa Davey from Guardian covered the research and the implications, interviewing Florence, me, and Ray Moynihan.
- Nicole Ostrow from Bloomberg covered the research and the implications, interviewing Florence, me, Christine Laine, and Austine Graff.
- Kimberly Leonard from US News covered our story and other recent news, interviewing Florence, me, including a statement from Genentech.
- Australian Doctor covered the research in a story (paywalled).
- The Wall Street Journal Pharmalot blog covered the story based on information from Bloomberg.
- A Newsweek article on data access in clinical trials described the study and linked to it.
- FiercePharma covered the story based on information from Bloomberg and other locations.
- Medscape covered the research based on what was written in the article.
- 2 minute medicine covered what was written in the article directly.
- Family Practice News and Internal Medicine News (among others in the same network) covered the research based on details from the article.
- The article summary was posted on MDLinx.
- The EurekAlert includes information from the tip sheet and a short summary of the article.
- Florence and I wrote a piece with help from Reema Rattan for The Conversation, describing the environment around industry influence, and the findings.
When I checked last (1 May 2015), the Altmetric score was 112. Here’s the low-tech way to check that…
Professor Adam G. Dunn 